Amgen to Buy Dezima Pharma, Collaborates with Xencor

21.09.2015 - US biopharmaceutical group Amgen is to acquire Dezima Pharma, a privately held Dutch biotechnology company focused on developing treatments for dyslipidemia. The transaction is...